光子计数乳腺计算机断层扫描、数字乳腺X线摄影与数字乳腺断层合成在乳腺标本评估中的表现
本研究将30例乳腺手术标本分别用数字乳腺X线摄影(DM)、数字乳腺断层合成(DBT)和光子计数乳腺CT(pcBCT)成像,由三名有经验的放射科医生对22处微钙化和23处肿块病灶进行判读并与病理对照。pcBCT对微钙化的敏感度85%、特异度83%,对病灶的敏感度65%、特异度76%,表现与临床已批准的DM和DBT相当或更优;作者指出使用对比剂可进一步提高肿块病灶的可检出性。
要点
- pcBCT对微钙化的敏感度85%、特异度83%,高于DM(82%/71%)和DBT(70%/75%)。
- pcBCT对病灶的敏感度65%,高于DM(45%)和DBT(62%),特异度76%与DM相同、高于DBT(62%)。
- 作者认为pcBCT表现与临床已批准的DM和DBT相当或更优,使用对比剂可进一步提高肿块病灶可检出性。
核心结论
- pcBCT在检测微钙化和病灶方面表现出与临床已批准的DM和DBT相当或更优的性能,使用对比剂可进一步提高肿块病灶的可检出性。
研究设计与样本
- 研究论文;共30例乳腺手术标本,分别用DM、DBT和pcBCT成像,由三名有经验的放射科医生判读;记录22处微钙化和23处肿块病灶,并与病理检查结果对照;计算敏感度和特异度并用受试者工作特征曲线展示。
关键影像表现/征象
- 微钙化:DM敏感度82%、特异度71%;DBT敏感度70%、特异度75%;pcBCT敏感度85%、特异度83%。
- 病灶:DM敏感度45%、特异度76%;DBT敏感度62%、特异度62%;pcBCT敏感度65%、特异度76%。
诊断标准与关键数值
- 微钙化检测敏感度:DM 82%,DBT 70%,pcBCT 85%。
- 微钙化检测特异度:DM 71%,DBT 75%,pcBCT 83%。
- 病灶检测敏感度:DM 45%,DBT 62%,pcBCT 65%。
- 病灶检测特异度:DM 76%,DBT 62%,pcBCT 76%。
临床应用与阅片要点
- 作者认为pcBCT表现与临床已批准的DM和DBT相当或更优。
- 作者指出使用对比剂可进一步提高肿块病灶的可检出性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: This study compared a novel photon-counting breast computed tomography (pcBCT) system with digital mammography (DM) and digital breast tomosynthesis (DBT) systems. For this reason, surgical specimens were examined with all three techniques and rated by three observers.
MATERIALS AND METHODS: A total of 30 surgical specimens were investigated with DM, DBT, and pcBCT; the associated images were shown to three experienced radiologists. Findings (22 microcalcifications and 23 mass lesions) were recorded and compared to the results of the pathological examination. Sensitivity and specificity for detection of microcalcifications and lesions were calculated and displayed using receiver operating characteristic curves.
RESULTS: Sensitivity for microcalcifications was 82% for DM, 70% for DBT, and 85% for pcBCT. Specificity for microcalcifications was 71% for DM, 75% for DBT, and 83% for pcBCT. Sensitivity for lesions was 45% for DM, 62% for DBT, and 65% for pcBCT. Specificity for lesions was 76% for DM, 62% for DBT, and 76% for pcBCT.
CONCLUSIONS: pcBCT showed a comparable or superior performance compared to the clinically approved DM and DBT systems. Mass lesion detectability can be increased further by the use of contrast media.
引用
- Rößler AC, Kalender W, Kolditz D, et al. Performance of Photon-Counting Breast Computed Tomography, Digital Mammography, and Digital Breast Tomosynthesis in Evaluating Breast Specimens. Acad Radiol. 2016. PMID: 27888024. doi:10.1016/j.acra.2016.09.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。